Evaluation of the sensitivities of six triple-negative breast cancer (TNBC) cell lines to 23 different PI3K/AKT/mTOR inhibitors or to a MEK inhibitor (trametinib). Dataset 1 of 2: GR values. - Dataset (ID:20364)

Filter results: >>>>
Cell line Drug name Experimental replicate Timepoint Drug concentration Live cell count Average live cell count, DMSO control Average live cell count (time = 0) Log10(drug concentration) GR value Relative cell count (treatment versus DMSO) Cell doublings (DMSO control) Experiment name
Hs 578T WYE-125132 3 72
1.0
1048.5 4195.3 571.3
0.0
0.235 0.250 2.876
Hs578T WYE125132 3
Hs 578T WYE-125132 3 72
0.1
1489.8 4195.3 571.3
-1.0
0.395 0.355 2.876
Hs578T WYE125132 3
Hs 578T WYE-125132 3 72
0.032
2208.3 4195.3 571.3
-1.49
0.600 0.526 2.876
Hs578T WYE125132 3
Hs 578T WYE-125132 3 72
0.01
3335.5 4195.3 571.3
-2.0
0.847 0.795 2.876
Hs578T WYE125132 3
Hs 578T WYE-125132 3 72
0.0032
3689.8 4195.3 571.3
-2.49
0.913 0.880 2.876
Hs578T WYE125132 3
Hs 578T WYE-125132 3 72
0.001
3852.0 4195.3 571.3
-3.0
0.942 0.918 2.876
Hs578T WYE125132 3
HCC1806 WYE-125132 2 72
0.001
11365.0 12050.8 1643.3
-3.0
0.960 0.943 2.874
HCC1806 WYE125132 0 2 72
Hs 578T CAL-101 3 72
3.2
3370.5 4189.5 571.3
0.505
0.854 0.805 2.874
Hs578T CAL101 3
Hs 578T CAL-101 3 72
0.032
4226.0 4189.5 571.3
-1.49
1.010 1.010 2.874
Hs578T CAL101 3
HCC1806 WYE-125132 2 72
0.32
5594.8 12050.8 1643.3
-0.495
0.531 0.464 2.874
HCC1806 WYE125132 0 2 72
Hs 578T CAL-101 3 72
0.0032
4192.0 4189.5 571.3
-2.49
1.000 1.000 2.874
Hs578T CAL101 3
HCC1806 WYE-125132 2 72
0.1
6801.8 12050.8 1643.3
-1.0
0.639 0.564 2.874
HCC1806 WYE125132 0 2 72
Hs 578T CAL-101 3 72
0.01
4238.3 4189.5 571.3
-2.0
1.010 1.010 2.874
Hs578T CAL101 3
Hs 578T CAL-101 3 72
0.1
4231.8 4189.5 571.3
-1.0
1.010 1.010 2.874
Hs578T CAL101 3
HCC1806 WYE-125132 2 72
1.0
5290.0 12050.8 1643.3
0.0
0.502 0.439 2.874
HCC1806 WYE125132 0 2 72
Hs 578T CAL-101 3 72
0.32
4090.8 4189.5 571.3
-0.495
0.983 0.976 2.874
Hs578T CAL101 3
HCC1806 WYE-125132 2 72
0.0032
11072.0 12050.8 1643.3
-2.49
0.942 0.919 2.874
HCC1806 WYE125132 0 2 72
HCC1806 WYE-125132 2 72
0.01
10352.8 12050.8 1643.3
-2.0
0.897 0.859 2.874
HCC1806 WYE125132 0 2 72
HCC1806 WYE-125132 2 72
3.2
5062.8 12050.8 1643.3
0.505
0.479 0.420 2.874
HCC1806 WYE125132 0 2 72
Hs 578T CAL-101 3 72
0.001
4189.5 4189.5 571.3
-3.0
1.000 1.000 2.874
Hs578T CAL101 3
HCC1806 WYE-125132 2 72
0.032
8601.3 12050.8 1643.3
-1.49
0.779 0.714 2.874
HCC1806 WYE125132 0 2 72
Hs 578T CAL-101 3 72
1.0
3764.0 4189.5 571.3
0.0
0.927 0.898 2.874
Hs578T CAL101 3
HCC1806 Everolimus 2 72
0.32
9042.0 12020.5 1643.3
-0.495
0.811 0.752 2.871
HCC1806 Everolimus 0 2 72
HCC1806 Everolimus 2 72
1.0
8742.8 12020.5 1643.3
0.0
0.790 0.727 2.871
HCC1806 Everolimus 0 2 72
HCC1806 Everolimus 2 72
0.1
9054.3 12020.5 1643.3
-1.0
0.812 0.753 2.871
HCC1806 Everolimus 0 2 72